Anaheim, CA , Oct. 16, 2018 (GLOBE NEWSWIRE) -- LiveWire Ergogenics, Inc. (OTC: LVVV) announced today that its subsidiary GHC Ventures has been granted a Distribution License by the California Bureau of Cannabis Control. LiveWire Ergogenics, Inc. is a company focused on the acquisition, licensing and management of special-purpose real estate properties and the development of turnkey production facilities for licensed cannabis-based operators.
This license positions GHC Ventures in a critical role in the safe and secure distribution of commercial cannabis goods between licensees throughout California. The license allows the company to purchase and sell cannabis goods between licensees and takes on the responsibility to arrange for third-party testing and quality assurance review of packaging and labeling. In addition to the State’s Track-and-Trace requirements, GHC will also implement LiveWire’s 7X Pure Cannabis Compliance and Verification System on products distributed through the supply chain and capitalize on the branding opportunity it affords.
Bill Hodson, CEO of LiveWire stated, “A State distribution license is a key component in the advancement of our unique business model and supports our efforts to become a prominent force in the California cannabis marketplace. We now have the ability to distribute not only a portfolio of quality brands, but also a full spectrum of products from multiple third party, licensed cultivators and manufactures and establish an additional revenue stream for the Company.”
Distribution is another crucial step in LiveWire's plans to establish one of the first vertically integrated and "closed-loop" cannabis operations in the State of California. This license establishes LiveWire in a strategic industry position as a potential partner for other State licensed operators.
About LiveWire Ergogenics, Inc.
LiveWire Ergogenics, Inc. (LVVV) specializes in identifying and monetizing current and future trends in the health and wellness industry. The Company is focused on acquiring, licensing and managing specialized turnkey cannabis real estate locations of fully compliant and permitted turnkey facilities for the production of cannabis-based products and services in California. The Company is also establishing select research partnerships to explore the application of cannabinoid-based products to target specific ailments or conditions with large “sufferer” populations for human and veterinarian applications. This includes dosing verification of zero pesticide products for quality brands via its “7X Pure” Cannabis Dosing and Verification System, and development and licensing of legal, high-quality cannabinoid-based products and services. LiveWire Ergogenics does not sell or distribute products that are in violation of the Unites States Controlled Substance Act and is only associated with companies that produce legally compliant products.
For more information about LiveWire Ergogenics, visit http://www.livewireergogenics.com. For non-material updates, follow LiveWire Ergogenics on Twitter @livewireLVVV. Download the Stockwatchindex Research Report at www.swiresearch.com/report-index
Forward-Looking Statements
Any statements contained in this press release that do not describe historical facts may constitute forward-looking statements. Forward-looking statements may include, without limitation, financial projections, statements regarding the plans and objectives of management for future operations, the development, regulatory approvals and commercialization of the Company’s products, or any of the Company’s other proposed products, systems or services. Such forward-looking statements are not meant to predict or guarantee actual results and performance, events or circumstances and actual events may differ considerably. Factors that may cause actual results to differ materially from any projections may include, without limitation, the Company’s inability to obtain additional financing, delays in the development of its products, the impact of significant new or changing government regulation in the cannabis industry, existing or increased competition, results of arbitration and litigation, stock volatility and illiquidity, and the Company’s failure to implement the Company’s business plans or strategies. The Company assumes no obligation to update any forward-looking statements to reflect any event or circumstance that may arise after the date of this release.